A-dopamine pump extends ON time for Parkinson’s patients

A new treatment called A-dopamine could give people with Parkinson’s disease more hours of symptom relief each day without the side effects of dyskinesia. A small clinical study found that patients gained an average of over four extra hours of good symptom control daily, along with 6.6 more hours of improved independence. Unlike traditional treatments, which often rely on oral medication, A-dopamine delivers a steady and stable supply of dopamine directly to the brain using a small pump placed in the abdomen. A thin tube connects the pump to the brain, targeting the area that controls movement. This innovative approach avoids the motor fluctuations and side effects that can come with increasing doses of oral medications as Parkinson’s progresses. The study involved 12 participants, who underwent a procedure under general anesthesia to implant the device. The surgery took less than four hours, and most patients recovered quickly, needing little or no pain medication. The pump, refilled every 7–15 days, helped provide consistent symptom control. Patients in the study reported no serious side effects. At higher doses, some experienced temporary nausea, drowsiness, or low blood pressure, but all who completed the study chose to continue using the treatment. This research, conducted in France, highlights a promising option for people who have struggled with current Parkinson’s therapies. The next step is a larger clinical trial to confirm these findings and make the treatment available as soon as possible. Experts involved in the study believe this approach could provide not only better care for Parkinson’s but also hope for other neurological conditions in the future.